TrialBMC psychiatry2026

Cost-benefit analysis of interpersonal therapy and fluoxetine for treating depression and PTSD in primary care settings in Kenya.

Easter Olwanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.